Patients With PH1 Treated With Lumasiran in France research hub

Retrospective and Prospective Follow-up of Patients With Primary Hyperoxaluria Type 1 Treated With Lumasiran in France.

This study in France looks at patients with a rare kidney disease called Primary Hyperoxaluria Type 1 (PH1) who are being treated with a medicine called Lumasiran. Researchers will follow them over 5 years to see how the treatment affects their health and kidney stone problems.